Sujuan Ba | CEO
AIM-HI Accelerator Fund, National Foundation for Cancer Research

Dr. Sujuan Ba is an internationally recognized leader in cancer research, dedicated to advancing scientific innovation and global collaboration to accelerate progress against cancer. She is the President and CEO of the National Foundation for Cancer Research (NFCR), which funds high-impact, high-risk cancer research. She also serves as CEO and Co-Founder of the AIM-HI Accelerator Fund, a nonprofit that invests in early-stage oncology startups. Dr. Ba also co-founded the Global Coalition for Adaptive Research, which launched the GBM AGILE platform—an innovative adaptive clinical trial for glioblastoma. She also established the Szent-Györgyi Prize for Progress in Cancer Research and the AIM-HI Venture Competition, supporting entrepreneurial scientists worldwide. Her contributions have earned global recognition, including OncoDaily’s 100 Most Influential CEOs in Oncology for 2025, the 2024 Pioneer in Medicine Award from the World Brain Mapping Foundation, the Trailblazer Award from The Serica Initiative, and the Leadership Award for Global Advocate of Cancer Research at BIOHK2023. She was named among the Top 300 Women Leaders in Global Health and received the inaugural CRS Women in Sciences Award, reflecting her lasting impact on cancer research and patient care worldwide.